Sinew Pharma Inc. (6634.TWO)
TWD 40.3
(15.31%)
TWD 40.3
(15.31%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.36 Billion TWD | -8.32% |
| 2022 | 1.48 Billion TWD | -6.16% |
| 2021 | 1.58 Billion TWD | 249.71% |
| 2020 | 453.15 Million TWD | 7.7% |
| 2019 | 420.77 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.29 Billion TWD | -5.14% |
| 2024 Q2 | 1.29 Billion TWD | 0.0% |
| 2023 Q3 | 1.36 Billion TWD | -5.29% |
| 2023 Q2 | 1.43 Billion TWD | 0.0% |
| 2023 Q4 | 1.36 Billion TWD | 0.0% |
| 2023 Q1 | 1.43 Billion TWD | -3.2% |
| 2022 Q4 | 1.48 Billion TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 53.002% |
| Level Biotechnology Inc. | 822.67 Million TWD | -65.725% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -105.104% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -148.452% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 64.987% |
| GlycoNex Incorporation | 1.55 Billion TWD | 12.2% |
| VBI | 452.1 Million TWD | -201.564% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -15.919% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -82.13% |
| Visgeneer Inc. | 397.17 Million TWD | -243.267% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 63.84% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 36.852% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -54.386% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 77.623% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1753.469% |
| Enimmune corporation | 604.82 Million TWD | -125.416% |
| TaiRx, Inc. | 833.74 Million TWD | -63.524% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 55.821% |
| EirGenix Inc. | 11.16 Billion TWD | 87.786% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -137.879% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 20.38% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 62.094% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -29.786% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -352.9% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -415.148% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -209.021% |
| RBC Bioscience Corporation | 753.79 Million TWD | -80.869% |
| BiOptic Inc. | 613.77 Million TWD | -122.13% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 23.349% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -17.561% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -111.425% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 56.109% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -964.746% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -260.336% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -20.244% |
| Neith Corporation | 192.15 Million TWD | -609.526% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -821.61% |
| NaviFUS Corp. | 490.53 Million TWD | -177.936% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -11.231% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -157.656% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -17.392% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 17.684% |
| AP Biosciences Inc | 890.75 Million TWD | -53.058% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 84.012% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -320.603% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | -2.229% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 49.711% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 91.126% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -232.321% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -243.548% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 34.324% |
| TCI GENE Inc. | 1.16 Billion TWD | -16.934% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -362.818% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | -0.003% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -44.769% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -95.2% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 65.518% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 64.334% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -10.858% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 75.671% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -28.377% |
| Acepodia, Inc. | 6.81 Billion TWD | 80.005% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 64.37% |